Skip to main content
Erschienen in: Rheumatology International 12/2013

01.12.2013 | Letter to the Editor

IRAK1, a potential therapeutic target for rheumatoid arthritis?

verfasst von: Qiang Xie, Shi-Cun Wang, Jun Li

Erschienen in: Rheumatology International | Ausgabe 12/2013

Einloggen, um Zugang zu erhalten

Excerpt

Rheumatoid arthritis (RA) is a chronic inflammatory disorder with hypertrophy, hyperplasia and angiogenesis of synovial tissue, which contribute to inflammatory joint destruction [1]. Although the exact causes of RA remain unknown, immunological dysregulation by inflammatory cytokines has been shown to be involved in driving the inflammation and synovial cell proliferation that characterize joint destruction in RA patients. …
Literatur
1.
Zurück zum Zitat Iguchi T, Ziff M (1986) Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 77:355–361PubMedCrossRef Iguchi T, Ziff M (1986) Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 77:355–361PubMedCrossRef
2.
Zurück zum Zitat Zhang H, Pu J, Wang X, Shen L, Zhao G, Zhuang C et al (2012) IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis. Rheumatol Int. doi:10.1007/s00296-012-2379-3 Zhang H, Pu J, Wang X, Shen L, Zhao G, Zhuang C et al (2012) IRAK1 rs3027898 C/A polymorphism is associated with risk of rheumatoid arthritis. Rheumatol Int. doi:10.​1007/​s00296-012-2379-3
3.
Zurück zum Zitat Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA (2010) A polymorphism in the 3′-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 77:411–413PubMedCrossRef Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA (2010) A polymorphism in the 3′-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 77:411–413PubMedCrossRef
4.
Zurück zum Zitat Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592:265–280PubMedCrossRef Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta 1592:265–280PubMedCrossRef
5.
Zurück zum Zitat Yokota K, Miyazaki T, Hemmatazad H, Gay RE, Kolling C, Fearon U et al (2011) The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. doi:10.1002/art.34318 Yokota K, Miyazaki T, Hemmatazad H, Gay RE, Kolling C, Fearon U et al (2011) The pattern-recognition receptor NOD1 promotes production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. doi:10.​1002/​art.​34318
6.
Zurück zum Zitat Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY (2007) Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108:121–128PubMedCrossRef Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY (2007) Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108:121–128PubMedCrossRef
7.
Zurück zum Zitat Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:R101PubMedCrossRef Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:R101PubMedCrossRef
8.
Zurück zum Zitat Mosaad YM, Abdelsalam A, El-Bassiony SR (2011) Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis. Int J Immunogenet 38:427–433PubMedCrossRef Mosaad YM, Abdelsalam A, El-Bassiony SR (2011) Association of tumour necrosis factor-alpha -308 G/A promoter polymorphism with susceptibility and disease profile of rheumatoid arthritis. Int J Immunogenet 38:427–433PubMedCrossRef
9.
Zurück zum Zitat Chiang EY, Yu X, Grogan JL (2011) Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J Immunol 186:1279–1288PubMedCrossRef Chiang EY, Yu X, Grogan JL (2011) Immune complex-mediated cell activation from systemic lupus erythematosus and rheumatoid arthritis patients elaborate different requirements for IRAK1/4 kinase activity across human cell types. J Immunol 186:1279–1288PubMedCrossRef
Metadaten
Titel
IRAK1, a potential therapeutic target for rheumatoid arthritis?
verfasst von
Qiang Xie
Shi-Cun Wang
Jun Li
Publikationsdatum
01.12.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 12/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2579-x

Weitere Artikel der Ausgabe 12/2013

Rheumatology International 12/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.